2023-11-23 18:16:24
Emmanuel Macron during his visit to the Novo Nordisk factory in Chartres this November 23, 2023. MOHAMMED BADRA/AFP
DECRYPTION – It announced Thursday an investment of 2.1 billion in its Chartres factory to meet demand for its flagship drugs.
It is a personal victory for Emmanuel Macron. Novo Nordisk, the world’s sixth largest pharmaceutical company, announced on Thursday an investment of 2.1 billion euros in its Chartres factory, a record amount in the health sector in France. Its CEO since 2017, Lars Fruergaard Jorgensen, paid tribute to Emmanuel Macron’s commitment. “We share the same long-term perspective, that of driving lasting change», he confides to Figaro.
A real satisfaction for the efforts made since the start of the five-year term by the Head of State in order to reindustrialize the country and strengthen its economic attractiveness, particularly in terms of health. In the midst of a pandemic, when France found itself running out of anesthetics and painkillers, he committed to reconquering the health sovereignty of France and allowing it to return to the forefront for pharmaceutical innovation. Several milestones have been reached in terms of relocation…
This article is reserved for subscribers. You have 83% left to discover.
Black Friday
-70% on digital subscription
Already subscribed? Log in
#Danish #laboratory #Novo #Nordisk #banking #France